US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IO Biotech, Inc.

0.9850

-0.0850-7.94%

Volume:65.29K

Turnover:66.29K

Market Cap:64.89M

PE:-0.68

High:1.10

Open:1.10

Low:0.9770

Close:1.07

Loading ...

Overview Company News Filings

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

Piper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)

IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Calendar of U.S. Earnings Expected in the Week Ahead

Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating

Wall Street Analysts Are Bullish on Top Healthcare Picks

IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

IO Biotech Advances Phase 3 Trial and Secures Financing

IO Biotech Reports 2024 Business Highlights

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

IO Biotech announces publication of preclinical data on IO112

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma

MT Newswires Live

IO Biotech completes enrollment in Phase 2 trial of IO102-IO103

IO Biotech Inc - Initial Data From Phase 2 Trial Expected in 2025

THOMSON REUTERS

IO Biotech Completes Enrollment in Phase 2 Trial of Its Investigational, off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients With Resectable Melanoma or Head and Neck Cancer

THOMSON REUTERS

IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer

BRIEF-IO Biotech Receives Nasdaq Notice For Minimum Bid Price Non-Compliance

IO Biotech Inc - Receives Nasdaq Notice for Minimum Bid Price Non-Compliance

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IOBT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IOBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOBT\",,,,,undefined,":{"symbol":"IOBT","market":"US","secType":"STK","nameCN":"IO Biotech, Inc.","latestPrice":0.985,"timestamp":1746648000000,"preClose":1.07,"halted":0,"volume":65287,"delay":0,"floatShares":31282748,"shares":65880914,"eps":-1.449448,"marketStatus":"Pre-Mkt","change":-0.085,"latestTime":"05-08 07:20:44 EDT","open":1.1,"high":1.1,"low":0.977,"amount":66293.007383,"amplitude":0.114953,"askPrice":1.1,"askSize":100,"bidPrice":0.8414,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.449448,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746711000000},"marketStatusCode":1,"adr":0,"listingDate":1636084800000,"exchange":"NASDAQ","adjPreClose":0.985,"postHourTrading":{"tag":"盘后","latestPrice":0.985,"preClose":0.985,"latestTime":"18:55 EDT","volume":130,"amount":127.7963,"timestamp":1746658513762},"volumeRatio":0.6638986855620659},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IOBT\",,,,,undefined,":{"symbol":"IOBT","floatShares":31282748,"roa":"-54.47%","roe":"-106.00%","lyrEps":-1.449448,"volumeRatio":0.6638986855620659,"shares":65880914,"dividePrice":0,"high":1.1,"amplitude":0.114953,"preClose":1.07,"low":0.977,"week52Low":0.66,"pbRate":"1.38","week52High":1.79,"institutionHeld":0,"latestPrice":0.985,"eps":-1.449448,"divideRate":0,"volume":65287,"delay":0,"ttmEps":-1.449448,"open":1.1,"prevYearClose":0.92,"prevWeekClose":1.02,"prevMonthClose":0.97,"prevQuarterClose":1.09,"fiveDayClose":0.97,"twentyDayClose":0.8322,"sixtyDayClose":0.9051},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IOBT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530763951","title":"IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530763951","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530763951?lang=en_us&edition=fundamental","pubTime":"2025-04-27 03:05","pubTimestamp":1745694300,"startTime":"0","endTime":"0","summary":"NEW YORK, April 26, 2025  -- IO Biotech , a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co-founders, Mads Hald Andersen, DMSc, PhD, Director of the National Center for Cancer Immune Therapy , chaired and presented at an educational session on cancer vaccines at the 2025 American Association for Cancer Research  Annual Meeting. The session brought together leading oncology scientists and explored the latest advancements in cancer vaccine research, from preclinical innovation to clinical implementation, providing perspective on the future of cancer vaccines and their potential to reshape cancer immunotherapy .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/io-biotech-showcases-scientific-leadership-190500312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4526","BK4531","LU1023057109.AUD","LU0359202008.SGD","BK4107","BK4139","SG9999011746.SGD","LU2039709279.SGD","BK4509","BK4535","LU0359201612.USD","IE00BYTNYN87.SGD","IE00BYQNZ168.SGD","BK4571","BK4563","01698","BK4117","IE00B12V2V27.USD","TME","IOBT","BK4565","AFG","BK4548","BK4108","BK4552"],"gpt_icon":0},{"id":"2524548465","title":"Piper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524548465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524548465?lang=en_us&edition=fundamental","pubTime":"2025-04-02 18:39","pubTimestamp":1743590377,"startTime":"0","endTime":"0","summary":"In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on IO Biotech (IOBT – Research Report), with a price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-io-biotech-iobt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-io-biotech-iobt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IOBT"],"gpt_icon":0},{"id":"2524190710","title":"IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190710?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:59","pubTimestamp":1743508740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IOBT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 07:59 ET (11:59 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2522838085","title":"IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838085","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838085?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:35","pubTimestamp":1742934900,"startTime":"0","endTime":"0","summary":"New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell activation, offering a distinct and complementary approach to checkpoint inhibitors New preclinical data for IO170 add to growing body of evidence supporting the potential of immune-modulatory therapeutic cancer vaccines to treat a wide range of cancers. “We are pleased to share new data at AACR that expand our understanding of the underlying mechanism of action of our lead candidate, IO102-IO103, currently being investigated in a pivotal Phase 3 trial,” said Ayako Wakatsuki Pedersen, PhD, Senior Vice President of Translational Research at IO Biotech. “We are also excited to share that we have seen promising activity for an additional candidate being studied in our pipeline, IO170. Together, the data from both of these non-clinical studies further solidify the potential of our proprietary T-winimmune-modulatory cancer vaccine platform.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/io-biotech-announces-acceptance-abstracts-203500610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4117","IOBT","BK4139","BK4107"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDLR","SURG","ANTX","TEN","THRD","WOOF","CNXC","SCS","UNCY","ALUR","FBIO","PAYS","SDST","XFOR","CHWY","OBIO","SKYX","GOVX","MKC","GRDN","SLRN","DERM","MDAI","PAYX","WGO","IVA","KBH","BCAB","ACRV","CTAS","CRMD","ZURA","CALC","IOBT","RVPH","WBA","AFMD","ABL","LPTX","MREO","EDAP","RLMD","MLKN","DLTR","KOD","BEEM","NUTX","PDSB","CLSD","IKT"],"gpt_icon":0},{"id":"2517653122","title":"Promising Clinical Developments and Delayed Data Boost IO Biotech’s Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517653122","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517653122?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:45","pubTimestamp":1741326344,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on IO Biotech (IOBT – Research Report), with a price target of $12.00. Emily Bodnar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-delayed-data-boost-io-biotechs-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-developments-and-delayed-data-boost-io-biotechs-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IOBT"],"gpt_icon":0},{"id":"2517512265","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2517512265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517512265?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:40","pubTimestamp":1741326013,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IO Biotech (IOBT – Research Report) and Elevation On...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-667?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-667?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4139","IOBT"],"gpt_icon":0},{"id":"2517618915","title":"IO Biotech Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517618915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517618915?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:05","pubTimestamp":1741176300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IOBT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 07:05 ET (12:05 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOBT"],"gpt_icon":0},{"id":"2517982403","title":"IO Biotech Advances Phase 3 Trial and Secures Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517982403","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517982403?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:16","pubTimestamp":1741126589,"startTime":"0","endTime":"0","summary":"An update from IO Biotech ( ($IOBT) ) is now available. On March 4, 2025, IO Biotech announced significant progress in its clinical trials and fina...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/io-biotech-advances-phase-3-trial-and-secures-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/io-biotech-advances-phase-3-trial-and-secures-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IOBT","BK4139"],"gpt_icon":0},{"id":"2517407989","title":"IO Biotech Reports 2024 Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2517407989","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517407989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:17","pubTimestamp":1741123020,"startTime":"0","endTime":"0","summary":"Preparations for submission of a Biologics License Application  for Cylembio  to FDA by year end 2025 remain on track.The trial completed enrollment in December 2023 ahead of plan with 407 patients. The primary endpoint of the pivotal Phase 3 trial is progression free survival ; the rate of PFS events has slowed and the readout of the primary endpoint is now expected in the third quarter of 2025. Dr. Zocca continued, “There is still a significant unmet medical need for new treatment options for patients suffering from advanced melanoma, metastatic head and neck cancer, and metastatic lung cancer. The full IO Biotech team is proud to be leading the next frontier of immune-oncology with the development of therapeutic cancer vaccines for these and other difficult-to-treat cancers. Our investigational therapeutic cancer vaccines are designed with a unique mechanism of action capable of targeting both immune-suppressive cells in the tumor microenvironment  and cancer cells, which have demon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/io-biotech-reports-2024-business-211700053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0985320562.USD","SG9999001440.SGD","SG9999014542.SGD","LU0861579265.USD","LU0208291251.USD","LU0965509283.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU0965509010.AUD","LU1069347547.HKD","LU0266013472.USD","LU0070302665.USD","IE00BBT3K403.USD","BK4559","LU0238689110.USD","LU2023250504.SGD","MRK","BK4534","LU0203345920.USD","LU2039709279.SGD","IE00BN8TJ469.HKD","LU1066051225.USD","SG9999002224.SGD","ORR","SG9999001176.USD","IE00BYTNYN87.SGD","PFS","LU2112291526.USD","LU0289739699.SGD","LU0006306889.USD","BK4139","LU1917777945.USD","BK4588","LU2468319806.SGD","IE000M9KFDE8.USD","SG9999001176.SGD","TME","LU2461242641.AUD","01698","LU1035773651.USD","BK4195","IE00BJT1NW94.SGD","SG9999002232.USD","LU1430594728.SGD","BK4563","LU0106261372.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","IOBT"],"gpt_icon":0},{"id":"2513022759","title":"IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2513022759","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513022759?lang=en_us&edition=fundamental","pubTime":"2025-02-24 01:07","pubTimestamp":1740330420,"startTime":"0","endTime":"0","summary":" Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF-β) in solid tumors NEW YORK, Feb.  23, 2025  (GLOBE NEWSWIRE) -- I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/23/3030818/0/en/IO-Biotech-Announces-New-Preclinical-Data-for-Additional-Pipeline-Candidate-Presented-at-the-AACR-IO-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK4565","TME","LU0359202008.SGD","LU0359201612.USD","IE00BYTNYN87.SGD","BK4108","IE00B12V2V27.USD","BK4509","BK4139","LU1023057109.AUD","IOBT","SG9999011746.SGD","BK4526","BK4571","BK4531","BK4548","01698","BK4552","IE00BYQNZ168.SGD","BK4535","BK4563"],"gpt_icon":0},{"id":"2508698459","title":"IO Biotech announces publication of preclinical data on IO112","url":"https://stock-news.laohu8.com/highlight/detail?id=2508698459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508698459?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:27","pubTimestamp":1738675628,"startTime":"0","endTime":"0","summary":"IO Biotech (IOBT) announced the publication of results from a preclinical study of its second immune-modulatory therapeutic cancer vaccine candidat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/io-biotech-announces-publication-of-preclinical-data-on-io112?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/io-biotech-announces-publication-of-preclinical-data-on-io112?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IO","BK4179","BK4139","BK4563","IOBT"],"gpt_icon":0},{"id":"2508456058","title":"IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456058","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456058?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:05","pubTimestamp":1738674300,"startTime":"0","endTime":"0","summary":"–Submission of Investigational New Drug Application (IND) to US FDA expected in 2025–  NEW YORK, Feb.  04, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical compa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/04/3020277/0/en/IO-Biotech-Announces-Publication-of-Preclinical-Data-Investigating-Immune-Modulatory-Effects-of-IO112-an-Arginase-1-Targeting-Therapeutic-Cancer-Vaccine-Candidate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IO","TME","BK4565","LU2039709279.SGD","BK4139","BK4108","LU0359201612.USD","LU0359202008.SGD","BK4571","BK4509","BK4548","01698","BK4535","IOBT","BK4179","IE00B12V2V27.USD","BK4531","IE00BYTNYN87.SGD","BK4552","BK4563","IE00BYQNZ168.SGD","BK4526","LU1023057109.AUD","SG9999011746.SGD"],"gpt_icon":0},{"id":"2502027888","title":"IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2502027888","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502027888?lang=en_us&edition=fundamental","pubTime":"2025-01-10 05:24","pubTimestamp":1736457877,"startTime":"0","endTime":"0","summary":"IO Biotech  said Thursday it completed enrollment ahead of schedule in a phase 2 trial of its cancer vaccine candidate IO102-IO103 combined with Merck's  Keytruda to treat people with resectable melanoma or squamous cell carcinoma of the head and neck.Initial data is expected this year, the company said.The trial has enrolled 93 people in the US, Europe and Australia, the company added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1989771016.USD","LU2089984988.USD","IE00BBT3K403.USD","LU1941712348.USD","SG9999014559.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1917777945.USD","LU1585245621.USD","LU1066051225.USD","IE00B2B36J28.USD","SG9999001176.USD","LU1934455277.USD","LU1941712264.USD","LU1974910355.USD","IE00BLSP4452.SGD","SG9999014575.USD","BK4559","LU1989772840.SGD","LU1989772923.USD","LU1116320901.HKD","IOBT","LU0006306889.USD","BK4179","IE0002141913.USD","LU2361045086.USD","IE00B1BXHZ80.USD","BK4534","LU0122379950.USD","LU0965509010.AUD","LU0070302665.USD","LU1037948541.HKD","MRK","LU2361044865.SGD","SG9999001440.SGD","LU0208291251.USD","LU1037948897.HKD","LU0861579265.USD","LU0106261372.USD","LU0234572021.USD","LU1066051498.USD","LU1934455863.HKD","IE0009355771.USD","LU0965509283.SGD","LU0211331839.USD","SG9999002224.SGD","LU0238689110.USD","LU1093756325.SGD","IO","LU0985320562.USD"],"gpt_icon":0},{"id":"2502010176","title":"IO Biotech completes enrollment in Phase 2 trial of IO102-IO103","url":"https://stock-news.laohu8.com/highlight/detail?id=2502010176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502010176?lang=en_us&edition=fundamental","pubTime":"2025-01-09 22:05","pubTimestamp":1736431514,"startTime":"0","endTime":"0","summary":"IO Biotech (IOBT) announced it has completed enrollment in its neoadjuvant/adjuvant Phase 2 basket trial, IOB-032/PN-E40. The trial is studying IO1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/io-biotech-completes-enrollment-in-phase-2-trial-of-io102-io103?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/io-biotech-completes-enrollment-in-phase-2-trial-of-io102-io103?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4563","IOBT","IO","BK4179"],"gpt_icon":0},{"id":"2502459011","title":"IO Biotech Inc - Initial Data From Phase 2 Trial Expected in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502459011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502459011?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nTUACGHDGV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2502119600","title":"IO Biotech Completes Enrollment in Phase 2 Trial of Its Investigational, off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients With Resectable Melanoma or Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2502119600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502119600?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nTUACGHDGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2502110280","title":"IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2502110280","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502110280?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427900,"startTime":"0","endTime":"0","summary":"-- Enrollment Completed Ahead of Schedule -- -- Initial Data Expected in 2025 -- NEW YORK, Jan.  09, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3007033/0/en/IO-Biotech-Completes-Enrollment-in-Phase-2-Trial-of-its-Investigational-Off-the-shelf-Therapeutic-Cancer-Vaccine-IO102-IO103-as-Neoadjuvant-Adjuvant-Treatment-for-Patients-with-Res.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0106831901.USD","LU1934455863.HKD","BK4108","LU0985320562.USD","IE00BJT1NW94.SGD","BK4552","LU2360107671.USD","LU1941712348.USD","LU1585245621.USD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","DFS","LU0006306889.USD","BK4588","LU0359202008.SGD","LU1093756325.SGD","LU1917777945.USD","IE0002141913.USD","IE00BN8TJ469.HKD","LU1430594728.SGD","MRK","LU0203345920.USD","01698","TME","BK4548","LU2361044949.HKD","LU1989771016.USD","SG9999015358.SGD","LU0265550359.USD","BK4531","LU2361045086.USD","LU1699723380.USD","IE00BYQNZ168.SGD","LU0965509101.SGD","LU1023057109.AUD","LU1983299246.USD","SGXZ57979304.SGD","BK4559","IOBT","IE00BBT3K403.USD","LU1791807156.HKD","BK4533","LU1571399168.USD","BK4166","LU2023250843.SGD","LU2106854487.HKD","IE00BLSP4239.USD","BK4516","IO"],"gpt_icon":0},{"id":"2494358136","title":"BRIEF-IO Biotech Receives Nasdaq Notice For Minimum Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2494358136","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494358136?lang=en_us&edition=fundamental","pubTime":"2024-12-28 05:18","pubTimestamp":1735334285,"startTime":"0","endTime":"0","summary":"BRIEF-IO Biotech Receives Nasdaq Notice For Minimum Bid Price Non-ComplianceDec 27 (Reuters) - IO Biotech Inc IOBT.O:IO BIOTECH INC - RECEIVES NASDAQ NOTICE FOR MINIMUM BID PRICE NON-COMPLIANCEFurther company coverage: IOBT.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nFWN3NS038:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IOBT"],"gpt_icon":0},{"id":"2494358187","title":"IO Biotech Inc - Receives Nasdaq Notice for Minimum Bid Price Non-Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2494358187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494358187?lang=en_us&edition=fundamental","pubTime":"2024-12-28 05:17","pubTimestamp":1735334239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241227:nFWN3NS038:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IOBT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IOBT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IOBT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IOBT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0,"sell":0,"strongSell":0.1667,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1734580800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IOBT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IOBT","date":"2025-05-07","current":-0.738212,"percent":0.848592,"low":-8.362196,"twenty":-1.701314,"median":-1.096903,"eighty":-0.763387,"high":-0.497352,"avg":-1.563825,"sd":1.338214,"marketCap":70492577},"quantilePoints":[{"date":"2021-11-05","current":-8.362196,"twenty":-8.009541,"median":-7.480559,"eighty":-7.480559,"marketCap":402631368},{"date":"2021-11-12","current":-6.882294,"twenty":-7.813632,"median":-7.480559,"eighty":-7.246158,"marketCap":331375570},{"date":"2021-11-19","current":-5.21259,"twenty":-7.538329,"median":-7.229401,"eighty":-6.446615,"marketCap":250980975},{"date":"2021-11-26","current":-4.554283,"twenty":-7.480559,"median":-6.702756,"eighty":-4.748184,"marketCap":219284181},{"date":"2021-12-03","current":-6.523218,"twenty":-7.438706,"median":-6.415495,"eighty":-4.69552,"marketCap":314086410},{"date":"2021-12-10","current":-6.313757,"twenty":-7.262915,"median":-6.313757,"eighty":-5.001932,"marketCap":304001066},{"date":"2021-12-17","current":-5.865823,"twenty":-7.15998,"median":-6.232964,"eighty":-5.216181,"marketCap":288152670},{"date":"2021-12-23","current":-4.839304,"twenty":-6.882294,"median":-6.068388,"eighty":-4.845169,"marketCap":237725952},{"date":"2021-12-31","current":-3.754126,"twenty":-6.702756,"median":-6.002557,"eighty":-4.632083,"marketCap":184417708},{"date":"2022-01-07","current":-4.065015,"twenty":-6.654879,"median":-5.730714,"eighty":-4.293782,"marketCap":199689800},{"date":"2022-01-14","current":-4.458025,"twenty":-6.523218,"median":-5.230543,"eighty":-4.249068,"marketCap":218996029},{"date":"2022-01-21","current":-3.757059,"twenty":-6.49928,"median":-4.949267,"eighty":-4.217538,"marketCap":184561785},{"date":"2022-01-28","current":-4.56361,"twenty":-6.373603,"median":-4.792377,"eighty":-4.181159,"marketCap":224182777},{"date":"2022-02-04","current":-4.77478,"twenty":-6.319742,"median":-4.77478,"eighty":-4.191764,"marketCap":234556273},{"date":"2022-02-11","current":-5.02701,"twenty":-6.308969,"median":-4.842237,"eighty":-4.217538,"marketCap":246946838},{"date":"2022-02-18","current":-4.985949,"twenty":-6.274258,"median":-4.880364,"eighty":-4.223392,"marketCap":244929769},{"date":"2022-02-25","current":-4.293782,"twenty":-6.226381,"median":-4.868633,"eighty":-4.223392,"marketCap":210927754},{"date":"2022-03-04","current":-3.619213,"twenty":-6.124643,"median":-4.815841,"eighty":-4.179986,"marketCap":177790197},{"date":"2022-03-11","current":-2.229013,"twenty":-6.067191,"median":-4.74545,"eighty":-4.127193,"marketCap":109498014},{"date":"2022-03-18","current":-2.328732,"twenty":-6.051631,"median":-4.669194,"eighty":-4.041552,"marketCap":114396609},{"date":"2022-03-25","current":-2.99157,"twenty":-6.019314,"median":-4.632083,"eighty":-3.853845,"marketCap":146957861},{"date":"2022-04-01","current":-2.406968,"twenty":-5.920517,"median":-4.558946,"eighty":-3.650888,"marketCap":163382563},{"date":"2022-04-08","current":-3.476731,"twenty":-5.865823,"median":-4.411099,"eighty":-3.379544,"marketCap":235997036},{"date":"2022-04-14","current":-3.052222,"twenty":-5.757735,"median":-4.293782,"eighty":-3.177027,"marketCap":207181769},{"date":"2022-04-22","current":-3.557388,"twenty":-5.590816,"median":-4.287916,"eighty":-3.161745,"marketCap":241471937},{"date":"2022-04-29","current":-3.077692,"twenty":-5.442398,"median":-4.249068,"eighty":-3.148161,"marketCap":208910685},{"date":"2022-05-06","current":-3.18382,"twenty":-5.223362,"median":-4.217526,"eighty":-3.136275,"marketCap":216114502},{"date":"2022-05-13","current":-3.196555,"twenty":-5.178246,"median":-4.182332,"eighty":-3.107832,"marketCap":216978960},{"date":"2022-05-20","current":-1.785565,"twenty":-5.112651,"median":-4.158868,"eighty":-3.076312,"marketCap":145228945},{"date":"2022-05-27","current":-1.611969,"twenty":-5.084495,"median":-4.106076,"eighty":-3.043189,"marketCap":131109464},{"date":"2022-06-03","current":-1.806822,"twenty":-5.064552,"median":-4.065015,"eighty":-2.850838,"marketCap":146957861},{"date":"2022-06-10","current":-1.647396,"twenty":-5.024664,"median":-4.003424,"eighty":-2.469511,"marketCap":133990991},{"date":"2022-06-17","current":-1.367516,"twenty":-5.012932,"median":-3.918369,"eighty":-2.352195,"marketCap":111226930},{"date":"2022-06-24","current":-1.711167,"twenty":-5.003547,"median":-3.754126,"eighty":-2.293537,"marketCap":139177739},{"date":"2022-07-01","current":-1.594255,"twenty":-4.997681,"median":-3.645609,"eighty":-2.229013,"marketCap":129668701},{"date":"2022-07-08","current":-1.718252,"twenty":-4.997681,"median":-3.557388,"eighty":-1.937905,"marketCap":139754044},{"date":"2022-07-15","current":-1.487971,"twenty":-4.988295,"median":-3.476731,"eighty":-1.820993,"marketCap":121024121},{"date":"2022-07-22","current":-1.516313,"twenty":-4.956603,"median":-3.36586,"eighty":-1.774937,"marketCap":123329342},{"date":"2022-07-29","current":-1.371059,"twenty":-4.936379,"median":-3.264179,"eighty":-1.717543,"marketCap":111515083},{"date":"2022-08-05","current":-1.459629,"twenty":-4.890923,"median":-3.210351,"eighty":-1.711167,"marketCap":118718900},{"date":"2022-08-12","current":-1.846922,"twenty":-4.870979,"median":-3.18382,"eighty":-1.705498,"marketCap":113532151},{"date":"2022-08-19","current":-1.664105,"twenty":-4.849862,"median":-3.171085,"eighty":-1.705498,"marketCap":102294197},{"date":"2022-08-26","current":-1.743795,"twenty":-4.840477,"median":-3.149859,"eighty":-1.691327,"marketCap":107192793},{"date":"2022-09-02","current":-1.509414,"twenty":-4.801762,"median":-3.128634,"eighty":-1.66223,"marketCap":92785159},{"date":"2022-09-09","current":-1.415661,"twenty":-4.781819,"median":-3.093612,"eighty":-1.651648,"marketCap":87022106},{"date":"2022-09-16","current":-1.469569,"twenty":-4.757182,"median":-3.077692,"eighty":-1.636768,"marketCap":90335862},{"date":"2022-09-23","current":-1.204718,"twenty":-4.741931,"median":-3.062835,"eighty":-1.612312,"marketCap":74055236},{"date":"2022-09-30","current":-1.270345,"twenty":-4.707909,"median":-3.038496,"eighty":-1.594255,"marketCap":78089373},{"date":"2022-10-07","current":-1.195343,"twenty":-4.665675,"median":-2.892613,"eighty":-1.555888,"marketCap":73478930},{"date":"2022-10-14","current":-1.115653,"twenty":-4.644558,"median":-2.52817,"eighty":-1.50934,"marketCap":68580335},{"date":"2022-10-21","current":-1.096903,"twenty":-4.635196,"median":-2.453475,"eighty":-1.474233,"marketCap":67427724},{"date":"2022-10-28","current":-1.129716,"twenty":-4.61772,"median":-2.375658,"eighty":-1.444696,"marketCap":69444793},{"date":"2022-11-04","current":-1.078153,"twenty":-4.581424,"median":-2.325799,"eighty":-1.427515,"marketCap":66275114},{"date":"2022-11-11","current":-1.182006,"twenty":-4.558014,"median":-2.252476,"eighty":-1.410974,"marketCap":85927126},{"date":"2022-11-18","current":-1.145539,"twenty":-4.496528,"median":-2.229013,"eighty":-1.403532,"marketCap":83276121},{"date":"2022-11-25","current":-1.070227,"twenty":-4.439255,"median":-2.188697,"eighty":-1.374602,"marketCap":77801220},{"date":"2022-12-02","current":-1.169322,"twenty":-4.394163,"median":-1.898486,"eighty":-1.367516,"marketCap":85005037},{"date":"2022-12-09","current":-1.105901,"twenty":-4.338769,"median":-1.885792,"eighty":-1.344134,"marketCap":80394594},{"date":"2022-12-16","current":-1.070227,"twenty":-4.293782,"median":-1.846922,"eighty":-1.290033,"marketCap":77801220},{"date":"2022-12-23","current":-1.050408,"twenty":-4.291436,"median":-1.815679,"eighty":-1.228405,"marketCap":76360457},{"date":"2022-12-30","current":-0.911675,"twenty":-4.287916,"median":-1.785565,"eighty":-1.200968,"marketCap":66275114},{"date":"2023-01-06","current":-0.990951,"twenty":-4.287916,"median":-1.778116,"eighty":-1.195343,"marketCap":72038167},{"date":"2023-01-13","current":-0.92753,"twenty":-4.276185,"median":-1.743795,"eighty":-1.17725,"marketCap":67427724},{"date":"2023-01-20","current":-1.169322,"twenty":-4.254491,"median":-1.725044,"eighty":-1.171905,"marketCap":85005037},{"date":"2023-01-27","current":-1.117793,"twenty":-4.228527,"median":-1.718252,"eighty":-1.169322,"marketCap":81259052},{"date":"2023-02-03","current":-1.070227,"twenty":-4.223392,"median":-1.714709,"eighty":-1.164792,"marketCap":77801220},{"date":"2023-02-10","current":-1.054372,"twenty":-4.214007,"median":-1.711167,"eighty":-1.156967,"marketCap":76648610},{"date":"2023-02-17","current":-1.038517,"twenty":-4.19763,"median":-1.701606,"eighty":-1.145539,"marketCap":75495999},{"date":"2023-02-24","current":-0.998879,"twenty":-4.187048,"median":-1.693453,"eighty":-1.134454,"marketCap":72614472},{"date":"2023-03-03","current":-1.038517,"twenty":-4.178812,"median":-1.664608,"eighty":-1.114923,"marketCap":75495999},{"date":"2023-03-10","current":-0.986987,"twenty":-4.169427,"median":-1.654482,"eighty":-1.106127,"marketCap":71750014},{"date":"2023-03-17","current":-0.79843,"twenty":-4.157695,"median":-1.647396,"eighty":-1.101937,"marketCap":57054228},{"date":"2023-03-24","current":-0.806495,"twenty":-4.145963,"median":-1.636768,"eighty":-1.096903,"marketCap":57630534},{"date":"2023-03-31","current":-0.756089,"twenty":-4.120154,"median":-1.627571,"eighty":-1.089039,"marketCap":54028625},{"date":"2023-04-06","current":-0.750041,"twenty":-4.096691,"median":-1.612255,"eighty":-1.078154,"marketCap":53596396},{"date":"2023-04-14","current":-0.745564,"twenty":-4.075574,"median":-1.607854,"eighty":-1.070227,"marketCap":53276547},{"date":"2023-04-21","current":-0.774235,"twenty":-4.05563,"median":-1.587169,"eighty":-1.062299,"marketCap":55325312},{"date":"2023-04-28","current":-0.762138,"twenty":-4.041552,"median":-1.55629,"eighty":-1.051994,"marketCap":54460854},{"date":"2023-05-05","current":-0.838755,"twenty":-4.01105,"median":-1.526926,"eighty":-1.042969,"marketCap":59935755},{"date":"2023-05-12","current":-0.868928,"twenty":-3.946525,"median":-1.509228,"eighty":-1.038517,"marketCap":61952824},{"date":"2023-05-19","current":-0.792139,"twenty":-3.918369,"median":-1.482657,"eighty":-1.030589,"marketCap":56477923},{"date":"2023-05-26","current":-0.812347,"twenty":-3.853845,"median":-1.459629,"eighty":-1.024247,"marketCap":57918686},{"date":"2023-06-02","current":-0.808305,"twenty":-3.756472,"median":-1.448428,"eighty":-1.014734,"marketCap":57630534},{"date":"2023-06-09","current":-0.838616,"twenty":-3.75178,"median":-1.432849,"eighty":-1.007599,"marketCap":59791679},{"date":"2023-06-16","current":-0.828513,"twenty":-3.728317,"median":-1.424201,"eighty":-1.002842,"marketCap":59071297},{"date":"2023-06-23","current":-0.763848,"twenty":-3.672005,"median":-1.415661,"eighty":-0.994915,"marketCap":54460854},{"date":"2023-06-30","current":-0.775973,"twenty":-3.629771,"median":-1.410974,"eighty":-0.986374,"marketCap":55325312},{"date":"2023-07-07","current":-0.739559,"twenty":-3.582118,"median":-1.406286,"eighty":-0.971132,"marketCap":52729057},{"date":"2023-07-14","current":-0.727475,"twenty":-3.557388,"median":-1.397629,"eighty":-0.943369,"marketCap":51867480},{"date":"2023-07-21","current":-0.759807,"twenty":-3.519182,"median":-1.374602,"eighty":-0.886566,"marketCap":54172701},{"date":"2023-07-28","current":-0.775973,"twenty":-3.483523,"median":-1.369287,"eighty":-0.858917,"marketCap":55325312},{"date":"2023-08-04","current":-0.755765,"twenty":-3.42579,"median":-1.360431,"eighty":-0.838699,"marketCap":53884549},{"date":"2023-08-11","current":-0.739599,"twenty":-3.379094,"median":-1.344488,"eighty":-0.829434,"marketCap":52731938},{"date":"2023-08-18","current":-1.727592,"twenty":-3.364911,"median":-1.360431,"eighty":-0.831552,"marketCap":127808973},{"date":"2023-08-25","current":-1.718687,"twenty":-3.346432,"median":-1.369287,"eighty":-0.834979,"marketCap":127150164},{"date":"2023-09-01","current":-1.638541,"twenty":-3.293165,"median":-1.374602,"eighty":-0.837808,"marketCap":121220881},{"date":"2023-09-08","current":-1.53346,"twenty":-3.249016,"median":-1.395858,"eighty":-0.838672,"marketCap":113446933},{"date":"2023-09-15","current":-1.309052,"twenty":-3.222026,"median":-1.38523,"eighty":-0.839508,"marketCap":96844943},{"date":"2023-09-22","current":-1.255621,"twenty":-3.211413,"median":-1.373473,"eighty":-0.840637,"marketCap":92892088},{"date":"2023-09-29","current":-1.18438,"twenty":-3.201649,"median":-1.367516,"eighty":-0.84311,"marketCap":87621615},{"date":"2023-10-06","current":-1.282336,"twenty":-3.191461,"median":-1.35941,"eighty":-0.854885,"marketCap":94868516},{"date":"2023-10-13","current":-1.032993,"twenty":-3.18382,"median":-1.343695,"eighty":-0.867744,"marketCap":76421860},{"date":"2023-10-20","current":-0.935037,"twenty":-3.180424,"median":-1.331284,"eighty":-0.868904,"marketCap":69174959},{"date":"2023-10-27","current":-0.80146,"twenty":-3.177028,"median":-1.317957,"eighty":-0.868507,"marketCap":59292822},{"date":"2023-11-03","current":-0.79398,"twenty":-3.168537,"median":-1.309052,"eighty":-0.840261,"marketCap":58739422},{"date":"2023-11-10","current":-0.83806,"twenty":-3.160047,"median":-1.282336,"eighty":-0.838505,"marketCap":62000528},{"date":"2023-11-17","current":-0.790436,"twenty":-3.151557,"median":-1.267435,"eighty":-0.831257,"marketCap":63212736},{"date":"2023-11-24","current":-0.963846,"twenty":-3.144765,"median":-1.260074,"eighty":-0.829434,"marketCap":77080669},{"date":"2023-12-01","current":-0.963846,"twenty":-3.136275,"median":-1.255621,"eighty":-0.830955,"marketCap":77080669},{"date":"2023-12-08","current":-1.079178,"twenty":-3.127784,"median":-1.242263,"eighty":-0.831846,"marketCap":86303997},{"date":"2023-12-15","current":-1.078436,"twenty":-3.113351,"median":-1.233295,"eighty":-0.832244,"marketCap":86244704},{"date":"2023-12-22","current":-1.202748,"twenty":-3.096795,"median":-1.228779,"eighty":-0.832554,"marketCap":96186134},{"date":"2023-12-29","current":-1.60641,"twenty":-3.092975,"median":-1.236756,"eighty":-0.834979,"marketCap":128467782},{"date":"2024-01-05","current":-1.589934,"twenty":-3.090428,"median":-1.237811,"eighty":-0.836889,"marketCap":127150164},{"date":"2024-01-12","current":-1.56522,"twenty":-3.087881,"median":-1.249155,"eighty":-0.838171,"marketCap":125173736},{"date":"2024-01-19","current":-1.48284,"twenty":-3.077692,"median":-1.255621,"eighty":-0.838616,"marketCap":118585645},{"date":"2024-01-26","current":-1.507554,"twenty":-3.075392,"median":-1.264526,"eighty":-0.838755,"marketCap":120562072},{"date":"2024-02-02","current":-1.48284,"twenty":-3.073447,"median":-1.272689,"eighty":-0.840637,"marketCap":118585645},{"date":"2024-02-09","current":-1.52403,"twenty":-3.052222,"median":-1.291241,"eighty":-0.840637,"marketCap":121879690},{"date":"2024-02-16","current":-1.252176,"twenty":-3.050228,"median":-1.309052,"eighty":-0.844561,"marketCap":100138989},{"date":"2024-02-23","current":-1.219224,"twenty":-3.040842,"median":-1.300147,"eighty":-0.846368,"marketCap":97503752},{"date":"2024-03-01","current":-1.31808,"twenty":-3.000955,"median":-1.291241,"eighty":-0.86295,"marketCap":105409462},{"date":"2024-03-08","current":-1.354614,"twenty":-2.968106,"median":-1.300147,"eighty":-0.867995,"marketCap":116609217},{"date":"2024-03-15","current":-1.301041,"twenty":-2.850838,"median":-1.309052,"eighty":-0.86876,"marketCap":111997553},{"date":"2024-03-22","current":-1.239816,"twenty":-2.816195,"median":-1.296141,"eighty":-0.86892,"marketCap":106727080},{"date":"2024-03-28","current":-1.324001,"twenty":-2.642701,"median":-1.304868,"eighty":-0.878628,"marketCap":113973981},{"date":"2024-04-05","current":-1.255122,"twenty":-2.492975,"median":-1.308695,"eighty":-0.886566,"marketCap":108044698},{"date":"2024-04-12","current":-1.22451,"twenty":-2.469511,"median":-1.296141,"eighty":-0.899403,"marketCap":105409462},{"date":"2024-04-19","current":-1.125018,"twenty":-2.450267,"median":-1.285128,"eighty":-0.909928,"marketCap":96844943},{"date":"2024-04-26","current":-1.109712,"twenty":-2.419156,"median":-1.275962,"eighty":-0.915006,"marketCap":95527325},{"date":"2024-05-03","current":-1.170937,"twenty":-2.388182,"median":-1.270345,"eighty":-0.923409,"marketCap":100797798},{"date":"2024-05-10","current":-1.209203,"twenty":-2.358061,"median":-1.263651,"eighty":-0.932034,"marketCap":104091844},{"date":"2024-05-17","current":-1.042231,"twenty":-2.335771,"median":-1.255621,"eighty":-0.94038,"marketCap":92233279},{"date":"2024-05-24","current":-0.982675,"twenty":-2.325212,"median":-1.255372,"eighty":-0.949934,"marketCap":86962806},{"date":"2024-05-31","current":-0.923119,"twenty":-2.311134,"median":-1.251885,"eighty":-0.938599,"marketCap":81692333},{"date":"2024-06-07","current":-0.930563,"twenty":-2.277113,"median":-1.246716,"eighty":-0.919584,"marketCap":82351142},{"date":"2024-06-14","current":-0.952897,"twenty":-2.251961,"median":-1.243938,"eighty":-0.91895,"marketCap":84327569},{"date":"2024-06-21","current":-0.915674,"twenty":-2.249899,"median":-1.239816,"eighty":-0.917227,"marketCap":81033524},{"date":"2024-06-28","current":-0.871007,"twenty":-2.241545,"median":-1.237811,"eighty":-0.916295,"marketCap":77080669},{"date":"2024-07-05","current":-0.841229,"twenty":-2.229013,"median":-1.2357,"eighty":-0.912475,"marketCap":74445432},{"date":"2024-07-12","current":-1.012453,"twenty":-2.221099,"median":-1.230471,"eighty":-0.907492,"marketCap":89598043},{"date":"2024-07-15","current":-0.962575,"twenty":-2.213185,"median":-1.228779,"eighty":-0.907676,"marketCap":85184021},{"date":"2024-08-02","current":-0.945452,"twenty":-2.205271,"median":-1.228468,"eighty":-0.907861,"marketCap":83668760},{"date":"2024-08-09","current":-1.072009,"twenty":-2.188548,"median":-1.22451,"eighty":-0.90823,"marketCap":94868516},{"date":"2024-08-16","current":-1.010627,"twenty":-2.044301,"median":-1.219224,"eighty":-0.910297,"marketCap":88939233},{"date":"2024-08-23","current":-1.19778,"twenty":-1.918505,"median":-1.209203,"eighty":-0.914074,"marketCap":105409462},{"date":"2024-08-30","current":-1.152864,"twenty":-1.89663,"median":-1.209203,"eighty":-0.915674,"marketCap":101456607},{"date":"2024-09-06","current":-0.670083,"twenty":-1.893975,"median":-1.206961,"eighty":-0.909608,"marketCap":58970006},{"date":"2024-09-13","current":-0.57486,"twenty":-1.887003,"median":-1.200031,"eighty":-0.896319,"marketCap":50589953},{"date":"2024-09-20","current":-0.890849,"twenty":-1.878912,"median":-1.196206,"eighty":-0.888868,"marketCap":78398287},{"date":"2024-09-27","current":-0.801016,"twenty":-1.865376,"median":-1.193105,"eighty":-0.873985,"marketCap":70492577},{"date":"2024-10-04","current":-0.756099,"twenty":-1.845047,"median":-1.187693,"eighty":-0.868904,"marketCap":66539723},{"date":"2024-10-11","current":-0.771071,"twenty":-1.835155,"median":-1.18438,"eighty":-0.863336,"marketCap":67857341},{"date":"2024-10-18","current":-0.905821,"twenty":-1.817817,"median":-1.182808,"eighty":-0.863336,"marketCap":79715905},{"date":"2024-10-25","current":-0.913308,"twenty":-1.807372,"median":-1.181213,"eighty":-0.867488,"marketCap":80374715},{"date":"2024-10-31","current":-0.958224,"twenty":-1.805224,"median":-1.178591,"eighty":-0.868277,"marketCap":84327569},{"date":"2024-11-08","current":-0.920794,"twenty":-1.796179,"median":-1.176301,"eighty":-0.868277,"marketCap":81033524},{"date":"2024-11-15","current":-0.649037,"twenty":-1.785565,"median":-1.171905,"eighty":-0.860905,"marketCap":58634013},{"date":"2024-11-22","current":-0.497352,"twenty":-1.785547,"median":-1.171905,"eighty":-0.841895,"marketCap":44930783},{"date":"2024-11-29","current":-0.649037,"twenty":-1.785475,"median":-1.170129,"eighty":-0.840637,"marketCap":58634013},{"date":"2024-12-06","current":-0.59726,"twenty":-1.781295,"median":-1.169322,"eighty":-0.83806,"marketCap":53956468},{"date":"2024-12-13","current":-0.577424,"twenty":-1.774937,"median":-1.163944,"eighty":-0.832038,"marketCap":52164507},{"date":"2024-12-20","current":-0.554307,"twenty":-1.774937,"median":-1.157842,"eighty":-0.828513,"marketCap":50076082},{"date":"2024-12-27","current":-0.6855,"twenty":-1.765557,"median":-1.155631,"eighty":-0.826658,"marketCap":61928059},{"date":"2025-01-03","current":-0.675144,"twenty":-1.751562,"median":-1.153467,"eighty":-0.823474,"marketCap":60992550},{"date":"2025-01-10","current":-0.627087,"twenty":-1.739246,"median":-1.148467,"eighty":-0.818687,"marketCap":56650997},{"date":"2025-01-17","current":-0.589967,"twenty":-1.730491,"median":-1.147978,"eighty":-0.812347,"marketCap":53297659},{"date":"2025-01-24","current":-0.65272,"twenty":-1.727082,"median":-1.145539,"eighty":-0.808305,"marketCap":58966712},{"date":"2025-01-31","current":-0.6855,"twenty":-1.724106,"median":-1.144307,"eighty":-0.808305,"marketCap":61928059},{"date":"2025-02-07","current":-0.707378,"twenty":-1.720022,"median":-1.140089,"eighty":-0.802467,"marketCap":63904486},{"date":"2025-02-14","current":-0.6855,"twenty":-1.7186,"median":-1.137612,"eighty":-0.798788,"marketCap":61928059},{"date":"2025-02-21","current":-0.809473,"twenty":-1.718252,"median":-1.132671,"eighty":-0.79843,"marketCap":73127814},{"date":"2025-02-28","current":-0.728745,"twenty":-1.718252,"median":-1.127372,"eighty":-0.792555,"marketCap":65834797},{"date":"2025-03-07","current":-0.668727,"twenty":-1.714709,"median":-1.125018,"eighty":-0.790436,"marketCap":60412798},{"date":"2025-03-14","current":-0.649037,"twenty":-1.714709,"median":-1.11908,"eighty":-0.786043,"marketCap":58634013},{"date":"2025-03-21","current":-0.692792,"twenty":-1.714709,"median":-1.117365,"eighty":-0.78261,"marketCap":62586868},{"date":"2025-03-28","current":-0.845936,"twenty":-1.711167,"median":-1.111847,"eighty":-0.7823,"marketCap":76421860},{"date":"2025-04-04","current":-0.693367,"twenty":-1.711167,"median":-1.107883,"eighty":-0.778268,"marketCap":66210318},{"date":"2025-04-11","current":-0.591811,"twenty":-1.709782,"median":-1.105901,"eighty":-0.775973,"marketCap":56512648},{"date":"2025-04-17","current":-0.614027,"twenty":-1.709782,"median":-1.101998,"eighty":-0.772585,"marketCap":58634013},{"date":"2025-04-25","current":-0.636656,"twenty":-1.708056,"median":-1.101937,"eighty":-0.76617,"marketCap":60794907},{"date":"2025-05-02","current":-0.696817,"twenty":-1.70281,"median":-1.097438,"eighty":-0.763848,"marketCap":66539723},{"date":"2025-05-07","current":-0.738212,"twenty":-1.701314,"median":-1.096903,"eighty":-0.763387,"marketCap":70492577}],"updateTime":1746703245014}}}